Copyright
©2011 Baishideng Publishing Group Co.
World J Hepatology. Oct 27, 2011; 3(10): 262-264
Published online Oct 27, 2011. doi: 10.4254/wjh.v3.i10.262
Published online Oct 27, 2011. doi: 10.4254/wjh.v3.i10.262
Complete response | No ascites |
Normal Na and creatinine with no or low-dose diuretics (spironolactone 75 mg or furosemide 40 mg/die) | |
Factor V increase > 40% of the normal range | |
Bilirubin decrease < 15 μmol/L | |
No portal hypertension bleeding | |
No spontaneous bacterial peritonitis | |
Body mass index > 20 kg/m2 | |
Ongoing response | Ascites detectable but responsive to low-dose diuretics |
Normal Na and creatinine | |
Factor V increase (if initially low) | |
Bilirubin decrease | |
Treatment failure | When criteria for complete or ongoing response were lacking |
- Citation: Mancuso A. Budd-Chiari syndrome management: Lights and shadows. World J Hepatology 2011; 3(10): 262-264
- URL: https://www.wjgnet.com/1948-5182/full/v3/i10/262.htm
- DOI: https://dx.doi.org/10.4254/wjh.v3.i10.262